Gabon vs Saudi Arabia: The number of people with susceptibility test result for rifampicin
Gabon
32.55
in 2021
Saudi Arabia
33.85
in 2021
Gabon rank
131st
Saudi Arabia rank
129th
The number of people with susceptibility test result for rifampicin over time
- Gabon
- Saudi Arabia
How they compare
Saudi Arabia currently reports 33.85 against 32.55 in Gabon, a difference of 1.3.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Saudi Arabia ahead.
Gabon ranks 131st and Saudi Arabia ranks 129th of 146 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.18 | 59.92 | 10.74 | Saudi Arabia |
| 2020s | 24.84 | 35.33 | 10.49 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Gabon or Saudi Arabia?
- Saudi Arabia, at 33.85 against 32.55 in Gabon as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Gabon and Saudi Arabia?
- 1.3, with Saudi Arabia ahead.
- How many years of comparable data are there for Gabon and Saudi Arabia?
- 5 years are reported by both, from 2017 to 2021.
- How do Gabon and Saudi Arabia rank globally for the number of people with susceptibility test result for rifampicin?
- Gabon ranks 131st and Saudi Arabia ranks 129th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.